https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/Novo-Nordisk-A-S-Risk-of-patient-overlap-between-Wegovy-and-Saxenda-obesity-drugs-Novo-says-35535084/?utm_source=telegram&utm_medium=social&utm_campaign=share